Disease Markers / 2019 / Article / Tab 2

Research Article

Prognostic Value of Combined Analysis of CTLA-4 and PLR in Esophageal Squamous Cell Carcinoma (ESCC) Patients

Table 2

Clinicopathological characteristics of ESCC patients.

Clinicopathological characteristicsT-CTLA-4(-) +PLR (-)Other value

Gender
 Male663036
 Female6240.686
Age (years)
 <70622735
 ≥7010550.703
KPS
 >80%391722
 ≤80%3315180.874
Weight loss (kg)
 <5502228
 ≥52210120.909
Drinking
 Yes321319
 No4019210.560
Smoking
 Yes462125
 No2611150.784
Histological differentiation
 Well and moderate391524
 Poor3317160.267
Location
 Proximal third734
 Middle third431726
 Distal third2212100.513
Tumor length (cm)
 <318108
 ≥35422320.273
Infiltration depth
 T1 and T2211110
 T3 and T45121300.384
Lymph node status
 N0472324
 N1259160.293
pTNM staging
 I and II482325
 III249150.402
Resection margin
 Positive312
 Negative6931381.000
Adjuvant radiotherapy
 Yes19712
 No5325280.437
Adjuvant chemotherapy
 Yes16511
 No5627290.228

Abbreviations: T-CTLA-4: tumor cell cytotoxic T-lymphocyte-associated antigen-4; PLR: platelet lymphocyte ratio; ESCC: esophageal squamous cell carcinoma; KPS: Karnofsky.